Avantor, Inc. has grown revenue −3.7% a year over three years and −0.33% a year over five. Revenue growth, 3-year annual rate: −3.7% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: −0.33%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

AVTRAvantor, Inc.

Healthcare

$15.67+25% 1Y

$15.67

$7.4152 weeks$15.85

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−20.8 points).

1 to watch, 1 neutral, 1 without data

Revenue trend−2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −0% a year.

Margin direction−20.8 points operating

Trailing-twelve-month operating margin, -4.6% now against 16.2% a year earlier.

All from SEC EDGAR, as of Mar 31, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbottom 9% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AVTR growing?

Avantor, Inc. has grown revenue −3.7% a year over three years and −0.33% a year over five.

−3.7%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −0.33%
Revenue growth, 5-year rate · −3.7% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›